PNV
Polynovo Ltd
Healthcare Equipment and Supplies
·
Healthcare
12
comments
4
fund managers
past 90 days
About Polynovo Ltd
Polynovo Ltd. is an Australian-headquartered medical device company specializing in patented NovoSorb biodegradable polymer technology. Its core product is the Biodegradable Temporizing Matrix (BTM), designed for advanced wound care. Founded in 1998, the company operates internationally across three primary geographical segments: the United States, Australia and New Zealand, and other global markets. Polynovo focuses on the research, development, and commercialization of medical solutions for therapeutic applications.
Commentary Volume
12
Comments
4
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$722M
Fund managers
4 managers
First covered
31 Jan 2024
Last updated
22 Jan 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Polynovo Ltd (ASX:PNV)
Frequently asked questions
Who is investing in Polynovo Ltd (ASX:PNV)?
Fund managers including Endeavor Asset Management, Blackwattle Investment Partners, Selector Funds Management and Forager Funds have invested in Polynovo Ltd (ASX:PNV).
What is the short interest in Polynovo Ltd (ASX:PNV)?
The short interest in Polynovo Ltd (ASX:PNV) is 11.35% which makes it the seventh most shorted stock on the ASX. Of the 690.8M shares that Polynovo Ltd has on issue, 78.4M have been sold short.
What does Polynovo Ltd (ASX:PNV) do?
Polynovo Ltd. is an Australian-headquartered medical device company specializing in patented NovoSorb biodegradable polymer technology. Its core product is the Biodegradable Temporizing Matrix (BTM), designed for advanced wound care. Founded in 1998, the company operates internationally across three primary geographical segments: the United States, Australia and New Zealand, and other global markets. Polynovo focuses on the research, development, and commercialization of medical solutions for therapeutic applications.
Loading...